AI models need more data about biology, and OpenAI is paying to create it
Last year, the clinical trial policy analyst Ruxandra Teslo posted an idea for super-charging medical AI systems: use data from failed biotech companies. By bidding at their bankruptcy proceedings, sh
事件进展（1 篇报道）
-
2026-09-15 20:00